Annual report pursuant to Section 13 and 15(d)

Commitments and Contingencies (Details Textual)

v3.7.0.1
Commitments and Contingencies (Details Textual)
 1 Months Ended
Aug. 04, 2017
USD ($)
Mar. 17, 2017
USD ($)
ft²
May 31, 2014
USD ($)
ft²
Sep. 30, 2014
USD ($)
Commitments And Contingencies [Line Items]        
Operating Leases, Rent Expense     $ 28,939  
Payments Of Monthly Lease Adjusted Annually Percentage     3.00%  
Adjusted Triple Net Expense Of Lease Payments     $ 34,381  
Area of Land | ft²     27,000  
Security Deposit     $ 750,000  
Proceeds from Other Deposits     $ 375,000  
Operating Leases [Member]        
Commitments And Contingencies [Line Items]        
Adjusted Triple Net Expense Of Lease Payments   $ 28,410    
Area of Land | ft²   20,000    
Security Deposit   $ 56,851    
Payments Of Monthly Lease Adjusted Annually   28,425    
Lease Expiration Period 82 months      
Sub-lease Income [Member]        
Commitments And Contingencies [Line Items]        
Adjusted Triple Net Expense Of Lease Payments   $ 12,828    
Area of Land | ft²   10,000    
Security Deposit   $ 25,046    
Payments Of Monthly Lease Adjusted Annually   $ 12,523    
Lease Expiration Period   82 months    
ActiveSite Pharmaceuticals, Inc. [Member]        
Commitments And Contingencies [Line Items]        
Upfront Payment, Payable $ 750,000      
Payment Execute Term 5 days      
Royalty, Percentage On Sales 2.00%      
Capital Lease Obligations        
Commitments And Contingencies [Line Items]        
Capital Lease Obligations       $ 8,075
Minimum | ActiveSite Pharmaceuticals, Inc. [Member]        
Commitments And Contingencies [Line Items]        
Milestone Payments $ 1,000,000      
Maximum | ActiveSite Pharmaceuticals, Inc. [Member]        
Commitments And Contingencies [Line Items]        
Milestone Payments $ 10,000,000